Henrik Bergentoft — CFO

Get alerts when Henrik Bergentoft trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Oncopeptides AB.

12-month summary

No open-market buys or sales in the last 12 months

0 open-market buys, 0 sales, 0 share awards

Roles

Oncopeptides AB Stockholm
CFO
16.09.2025 – 16.03.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
16.03.2026Oncopeptides AB Stockholm
New shares (subscription)
14,258SEK 1.55
SEK 22,099.90
↗
16.09.2025Oncopeptides AB Stockholm
New shares (subscription)
5,184SEK 3.20
SEK 16,588.80
↗